2013—2015年苏州大学附属常熟医院降血脂药应用分析  

Analysis on Application of Hypolipidemic Drugs in Changshu Hospital Affiliated to Soochow University During 2013-2015

作　　者：陆益[1] 张桂芬[1] 

机构地区：[1]苏州大学附属常熟医院药剂科,江苏常熟215500

出　　处：《中国医院用药评价与分析》2017年第2期235-238,共4页Evaluation and Analysis of Drug-use in Hospitals of China

摘　　要：目的:了解苏州大学附属常熟医院(以下简称"该院")降血脂药应用现状及趋势,为临床合理用药提供参考。方法:对2013—2015年该院降血脂药的销售金额、用药频度(defined daily dose system,DDDs)及限定日费用(defined daily cost,DDC)等进行统计、分析,利用排序比(药品销售金额排序/DDDs排序)对药物使用的同步性进行比较。结果:2013—2015年,该院降血脂药的销售金额分别为187.03、289.44、399.11万元,2014和2015年分别比上一年增长了54.75%和37.89%;该院西药总销售金额分别为28 643.34、31 240.22、33 293.75万元,降血脂药销售金额占西药总销售金额的比例分别为0.65%、0.93%、1.20%;他汀类药物销售金额占降血脂药销售金额的比例、他汀类药物DDDs占降血脂药DDDs的比例均呈逐年大幅度上升趋势;瑞舒伐他汀的销售金额和DDDs排序均居首位,且逐年增长,同步性良好。结论:他汀类药物是临床首选,该院降血脂药的使用基本合理,符合降血脂药的发展趋势。OBJECTIVE ：To investigate the application status and the tendency of hypolipidemic drugs in Changshu Hospital Affiliated to Soochow University （ hereinafter referred to as ＂the hospital＂ ） during 2013-2015. METHODS： Statistical analysis was conducted on application data of hypolipidemic drugs in terms of consumption sum, defined daily dose system （DDDs） and defined daily cost （DDC）, etc. The synchronous correlation in application of the hypolipidemic drugs was evaluated by using the ratio of serial numbers. RESULTS： During 2013-2015, the consumption sum of the hypolipidemic drugs were respectively 1. 870 3 million yuan, 2. 894 4 million yuan and 3. 991 1 million yuan, and increased by 54. 75% and 37.89% in 2014 and 2015 respectively. The consumption sum of western medicine were respectively 286. 433 4 million yuan,312. 402 2 million yuan and 332. 937 5 million yuan, the ratio of consumption sum of hypolipidemic drugs versus the total consumption sum of western medicine were respectively 0.65% , 0.93% and 1.20%. The proportion of the consumption sum and DDDs of statin-related drugs in hypolipidemic drugs were in an increasing tendency year by year. The consumption sum and DDDs of rosuvastatin took the lead, and also in an increasing tendency with good synchronicity. CONCLUSIONS： Statins is the first choice of clinical drug application. The application of hypolipidemic drugs used in the hospital is basically rational and in line with the development trend of hypolipidemic drugs.

关 键 词：降血脂药 他汀类药物 瑞舒伐他汀 销售金额 用药频度 用药分析 

分 类 号：R972.6[医药卫生—药品]